Postmortem molecular screening for cardiac ryanodine receptor type 2 mutations in sudden unexplained death - R420W mutated case with characteristics of status thymico-lymphaticus

Circulation Journal

Volumn 70, Issue 11, 2006, Pages 1402-1406

  Nishio, Hajime ^a   Iwata, Misa ^a   Suzuki, Koichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Arrhythmia; Autopsy; Calcium; Sudden death; Thymus

Indexed keywords

NUCLEOTIDE; RYANODINE RECEPTOR; RYANODINE RECEPTOR TYPE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AORTA CONSTRICTION; ARTICLE; AUTOPSY; CARDIOVASCULAR SYSTEM; CHILD; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; HYPOPLASIA; LYMPHOID HYPERPLASIA; MALE; MESENTERY LYMPH NODE; MISSENSE MUTATION; SUDDEN DEATH; THYMUS; TONSIL DISEASE;

ADOLESCENT; ADULT; AUTOPSY; CARDIOVASCULAR SYSTEM; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DIAGNOSIS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC SCREENING; HUMANS; LYMPHATIC SYSTEM; MALE; MUTATION, MISSENSE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THYMUS GLAND;

EID: 33750571687     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1402     Document Type: Article

References (29)

1. Morentin B, Suarez-Mier MP, Aguilera B. Sudden unexplained death among persons 1-35 years old. Forensic Sci Int 2003; 135: 213-217.
2. Chugh SS, Senashova O, Watts A, Tran PT, Zhou Z, Gong Q, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol 2004; 43: 1625-1629.
3. Ackerman MJ, Tester DJ, Driscoll DJ. Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol 2001; 22: 105-111.
4. Wedekind H, Bajanowski T, Friederich P, Breithardt G, Wülfing T, Siebrands C, et al. Sudden infant death syndrome and long QT syndrome: An epidemiological and genetic study. Int J Leg Med 2006; 120: 129-137.
5. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 2004; 79: 1380-1384.
6. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994; 77: 513-523.
7. Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002; 40: 341-349.
8. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.
9. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74.
10. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189-194.
11. Nava A, Canciani B, Daliento L, Miraglia G, Buja G, Fasoli G, et al. Juvenile sudden death and effort ventricular tachycardias in a family with right ventricular cardiomyopathy. Int J Cardiol 1988; 21: 111-126.
12. d'Amati G, Bagattin A, Bauce B, Rampazzo A, Autore C, Basso C, et al. Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: Evidence of specific morphological substrates. Hum Pathol 2005; 36: 761-767.
13. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485-490.
14. Paltauf A. Über die Beziehung der Thymus zum plötzlichen Tod. Wien Klin Wochenschr 1889; 2: 877-881.
15. Dally A. Status lymphaticus: Sudden death in children from "visitation of God" to cot death. Med Hist 1997; 41: 70-85.
16. Symmers D. Status lymphaticus. Am J Med Sci 1918; 156: 40-59.
17. Willson D. Status thymicolymphaticus: Presentation and discussion of a case. Curr Res Anesth Analgesia 1950; 29: 356-358.
18. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 1099-1105.
19. Investigation Committee of the Medico-Legal Society of Japan. Reports on medico-legal data from massive investigation performed by the medico-legal society of Japan: Weight and size of internal organs of normal Japanese today. Jpn J Leg Med 1992; 46: 225-235.
20. Giannini G, Conti A, Mammarella S, Scrobogna M, Sorrentino V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J Cell Biol 1995; 128: 893-904.
21. Komazaki S, Ikemoto T, Takeshima H, Iino M, Endo M, Nakamura H. Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors. Cell Tissue Res 1998; 294: 467-473.
22. 2+/calmodulin-dependent kinase type IV/Gr in setting the thymocyte selection threshold. J Immunol 2001; 167: 6270-6278.
23. Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporine A on T cell development and clonal deletion. Science 1988; 241: 1655-1658.
24. Gao EK, Lo D, Cheney R, Kanagawa O, Sprent J. Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature 1988; 336: 176-179.
25. Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 2006; 21: 166-172.
26. Richter S, Duray G, Grönefeld G, Israel CW, Hohnloser SH. Prevention of sudden cardiac death: Lessons from recent controlled trials. Circ J 2005; 69: 625-629.
27. Kurita T, Mitamura H, Aizawa Y, Nitta T, Aonuma K, Tsuboi N, et al. Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: The Nippon ICD Plus Pharmachologic Option Necessity study design. Circ J 2006; 70: 316-320.
28. Watanabe H, Chinushi M, Washizuka T, Sugiura H, Hirono T, Aizawa Y, et al. Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias. Circ J 2006; 70: 583-587.
29. Satomi K, Kurita T, Takatsuki S, Yokoyama Y, Chinushi M, Tsuboi N, et al. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias. Circ J 2006; 70: 977-984.